Figure 1From: Efficacy, safety and tolerability of GSK2190915, a 5-lipoxygenase activating protein inhibitor, in adults and adolescents with persistent asthma: a randomised dose-ranging studyCONSORT diagram. Subject flow through study. FP = fluticasone propionate.Back to article page